149 related articles for article (PubMed ID: 38116847)
1. Oncology for the rhinologist.
Tam K; Dunn LA; Cohen MA
Curr Opin Otolaryngol Head Neck Surg; 2024 Feb; 32(1):14-19. PubMed ID: 38116847
[TBL] [Abstract][Full Text] [Related]
2. The Role of Induction Therapy for Sinonasal Cancers.
Kong KA; Thorp BD; Sheth SH
Curr Treat Options Oncol; 2023 Mar; 24(3):162-169. PubMed ID: 36696082
[TBL] [Abstract][Full Text] [Related]
3. Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma.
Takahashi Y; Gleber-Netto FO; Bell D; Roberts D; Xie TX; Abdelmeguid AS; Pickering C; Myers JN; Hanna EY
Oral Oncol; 2019 Oct; 97():56-61. PubMed ID: 31421472
[TBL] [Abstract][Full Text] [Related]
4. Sinonasal Undifferentiated Carcinoma.
Abdelmeguid AS; Bell D; Hanna EY
Curr Oncol Rep; 2019 Feb; 21(3):26. PubMed ID: 30806835
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine Carcinoma and Sinonasal Undifferentiated Carcinoma.
Abdelmeguid AS; Bell D; Hanna EY
Adv Otorhinolaryngol; 2020; 84():168-184. PubMed ID: 32731236
[TBL] [Abstract][Full Text] [Related]
6. Induction Chemotherapy for Locoregionally Advanced Sinonasal Squamous Cell Carcinoma and Sinonasal Undifferentiated Carcinoma: A Comprehensive Review.
Melder KL; Geltzeiler M
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568614
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: The importance of differentiation grade in determining treatment strategy.
van der Laan TP; Iepsma R; Witjes MJ; van der Laan BF; Plaat BE; Halmos GB
Oral Oncol; 2016 Dec; 63():1-9. PubMed ID: 27938993
[TBL] [Abstract][Full Text] [Related]
8. Oncologic management of sinonasal undifferentiated carcinoma.
Tyler MA; Holmes B; Patel ZM
Curr Opin Otolaryngol Head Neck Surg; 2019 Feb; 27(1):59-66. PubMed ID: 30507692
[TBL] [Abstract][Full Text] [Related]
9. Sinonasal undifferentiated carcinoma: Institutional trend toward induction chemotherapy followed by definitive chemoradiation.
London NR; Mohyeldin A; Daoud G; Gamez ME; Blakaj D; Bonomi M; Prevedello DM; Carrau RL
Head Neck; 2020 Nov; 42(11):3197-3205. PubMed ID: 32681692
[TBL] [Abstract][Full Text] [Related]
10. Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase.
Mehta GU; Raza SM; Su SY; Hanna EY; DeMonte F
J Neurooncol; 2020 Dec; 150(3):367-375. PubMed ID: 32424573
[TBL] [Abstract][Full Text] [Related]
11. Impact of induction chemotherapy and socioeconomics on sinonasal undifferentiated carcinoma survival.
Lehrich BM; Goshtasbi K; Abiri A; Yasaka T; Sahyouni R; Papagiannopoulos P; Tajudeen BA; Kuan EC
Int Forum Allergy Rhinol; 2020 May; 10(5):679-688. PubMed ID: 32104985
[TBL] [Abstract][Full Text] [Related]
12. The role of systemic therapy in the management of sinonasal cancer: A critical review.
Bossi P; Saba NF; Vermorken JB; Strojan P; Pala L; de Bree R; Rodrigo JP; Lopez F; Hanna EY; Haigentz M; Takes RP; Slootweg PJ; Silver CE; Rinaldo A; Ferlito A
Cancer Treat Rev; 2015 Dec; 41(10):836-43. PubMed ID: 26255226
[TBL] [Abstract][Full Text] [Related]
13. Sinonasal malignancies with neuroendocrine differentiation: case series and review of literature.
Menon S; Pai P; Sengar M; Aggarwal JP; Kane SV
Indian J Pathol Microbiol; 2010; 53(1):28-34. PubMed ID: 20090218
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel diagnostic markers for sinonasal undifferentiated carcinoma.
Takahashi Y; Gleber-Netto FO; Bell D; Roberts D; Xie TX; Abdelmeguid AS; Pickering C; Myers JN; Hanna EY
Head Neck; 2019 Aug; 41(8):2688-2695. PubMed ID: 30932264
[TBL] [Abstract][Full Text] [Related]
15. Sinonasal undifferentiated carcinoma: clinicopathological spectrums and diagnosis reappraisal.
Vaziri Fard E; Zhang S; Cai Z; Ding J; Sun Q; Saluja K; Zhu H
Hum Pathol; 2019 Jul; 89():62-70. PubMed ID: 31054892
[TBL] [Abstract][Full Text] [Related]
16. Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma.
Amit M; Abdelmeguid AS; Watcherporn T; Takahashi H; Tam S; Bell D; Ferrarotto R; Glisson B; Kupferman ME; Roberts DB; Su SY; Raza SM; DeMonte F; Hanna EY
J Clin Oncol; 2019 Feb; 37(6):504-512. PubMed ID: 30615549
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses.
Abdelmeguid AS; Teeramatwanich W; Roberts DB; Amit M; Ferraroto R; Glisson BS; Kupferman ME; Su SY; Phan J; Garden AS; Raza SM; DeMonte F; Hanna EY
Cancer; 2021 Jun; 127(11):1788-1795. PubMed ID: 33567468
[TBL] [Abstract][Full Text] [Related]
18. High-grade sinonasal carcinomas and surveillance of differential expression in immune related transcriptome.
Bell D; Bell A; Ferrarotto R; Glisson B; Takahashi Y; Fuller G; Weber R; Hanna E
Ann Diagn Pathol; 2020 Dec; 49():151622. PubMed ID: 32927372
[TBL] [Abstract][Full Text] [Related]
19. Sinonasal undifferentiated carcinoma: clinical and pathologic features and a discussion on classification, cellular differentiation, and differential diagnosis.
Ejaz A; Wenig BM
Adv Anat Pathol; 2005 May; 12(3):134-43. PubMed ID: 15900114
[TBL] [Abstract][Full Text] [Related]
20. Modern treatment of sinonasal undifferentiated carcinoma.
Neo WL; Hanna EY; Kiong KL
Curr Opin Otolaryngol Head Neck Surg; 2023 Apr; 31(2):89-93. PubMed ID: 36912221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
